Lifevantage grants director Darwin Lewis 17,888 shares

The 17,888-share director award is scheduled to vest in one installment on November 5, 2027, subject to continuous service.

Available on EDGAR 11/09/2026 - 05:00 PM EST Accepted by SEC EDGAR 11/09/2026 - 05:00 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Lifevantage Corp director Darwin Lewis received a grant of 17,888 common shares on November 5, 2026, under the company’s outside director compensation program. The shares will vest in a single installment on November 5, 2027, subject to his continuous service through that date. The reported $5.87 per share is the weighted average closing price for the ten trading days ending the day before the grant. Lewis reported direct holdings of 156,132 shares following the grant.

Insider Trade Summary

Grant/Award: 17,888 shares

Grant/Award 1 txn

Insider Lewis Darwin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	17,888	$5.87	$105K

Holdings After Transaction: Common Stock — 156,132 shares (Direct)

Footnotes (2)

1. F1. These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 5, 2027, subject to the reporting person's continuous service to the issuer through such date.
2. F2. The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant.

Key Figures

Common shares granted: 17,888 shares Weighted average closing price: $5.87 per share Direct shares following grant: 156,132 shares

3 metrics

Common shares granted 17,888 shares Grant on November 5, 2026

Weighted average closing price $5.87 per share For the ten trading days ending the day before the grant

Direct shares following grant 156,132 shares Darwin Lewis’s reported holdings after the grant

Key Terms

outside director compensation program, weighted average closing price, vest in a single installment

3 terms

outside director compensation program financial

"pursuant to the issuer's outside director compensation program"

weighted average closing price financial

"equal to the weighted average closing price"

vest in a single installment technical

"will vest in a single installment on November 5, 2027"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LFVN shares did director Darwin Lewis receive?

Darwin Lewis received a grant of 17,888 common shares on November 5, 2026, under Lifevantage Corp’s outside director compensation program. He reported direct holdings of 156,132 shares following the grant.

When do Darwin Lewis’s LFVN shares vest?

The 17,888 shares are scheduled to vest in a single installment on November 5, 2027, subject to Lewis’s continuous service to Lifevantage Corp through that date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lewis Darwin

(Last) (First) (Middle)

3300 TRIUMPH BLVD, SUITE 700

(Street)

LEHI UTAH 84043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/05/2026		A		17,888(1)	A	$5.87(2)	156,132	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 5, 2027, subject to the reporting person's continuous service to the issuer through such date.

2. The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant.

	/s/ Darwin Lewis	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)